Quarterly Results

  • Company Name :
Concord Biotech Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 543960
  • NSE Symbol:
  • CONCORDBIO
  • P/E(TTM):
  • 35.61
  • ISIN Demat:
  • INE338H01029
  • Div & Yield%:
  • 0.81
  • EPS(TTM):
  • 30.36
  • Book Value(₹):
  • 174.47
  • Market Cap(₹Cr.):
  • 11,311.63
  • Face Value(₹):
  • 1.00
Quarters :  
Particulars December 2025 ( Cr)September 2025 ( Cr)June 2025 ( Cr)
Gross Sales 278.13 247.06 203.99
Excise Duty 0.00 0.00 0.00
Net Sales 278.13 247.06 203.99
Other Operating Income 0.00 0.00 0.00
Other Income 10.08 13.43 13.68
Total Income 288.22 260.49 217.67
Total Expenditure 179.19 156.52 142.59
PBIDT 109.03 103.97 75.07
Interest 0.06 0.06 0.06
PBDT 108.97 103.91 75.02
Depreciation 18.67 18.39 17.78
Tax 21.57 22.00 14.08
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 0.95 0.63 0.60
Reported Profit After Tax 67.78 62.90 42.57
Extra-ordinary Items -2.46 0.00 0.00
Adjusted Profit After Extra-ordinary item 70.24 62.90 42.57
EPS (Unit Curr.) 6.48 6.01 4.07
EPS (Adj) (Unit Curr.) 6.48 6.01 4.07
Calculated EPS (Unit Curr.) 6.48 6.01 4.07
Calculated EPS (Adj) (Unit Curr.) 6.48 6.01 4.07
Calculated EPS (Ann.) (Unit Curr.) 25.92 24.05 16.27
Calculated EPS (Adj) (Ann.) (Unit Curr.) 25.92 24.05 16.27
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 10.46 10.46 10.46
Reserve & Surplus 0.00 0.00 0.00
Face Value 1.00 1.00 1.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 39.20 42.08 36.80
PBDTM(%) 39.18 42.06 36.78
PATM(%) 24.37 25.46 20.87